Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations

The Lancet

Volumn 336, Issue 8723, 1990, Pages 1087-1090

  Cromme Dijkhuis, A H ^a   Bijleveld, C M A ^a   Henkens, C M A ^b   Hillege, H L ^b   Bom, V J J ^b   vd Meer, J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Division of Pediatric Gastroenterology Department of Internal Medicine University Hospital ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; PROTEIN C; PROTHROMBIN;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS;

ADOLESCENT; ADULT; ANASTOMOSIS, SURGICAL; ANTITHROMBIN III DEFICIENCY; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; FACTOR X DEFICIENCY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMAN; HYPOPROTHROMBINEMIAS; LIVER FUNCTION TESTS; MALE; POSTOPERATIVE COMPLICATIONS; PROTEIN C DEFICIENCY; REOPERATION; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS; TRICUSPID VALVE;

EID: 0025168910     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)92568-3     Document Type: Article

References (23)

1. Surgical repair of tricuspid atresia
2. Fontan procedure-indication and clinical results
3. Long-term results after the Fontan operation for tricuspid atresia
4. Protein losing enteropathy after Fontan operation
5. Liver fibrosis (cardiac cirrhosis) five years after modified Fontan operation for tricuspid atresia
6. Atrial thrombi after the Fontan operation
7. A new vitamin K dependent protein: purification from bovine plasma and preliminary characterisation
8. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme
9. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor-no evidence for a cofactor role of protein S
10. Protein S and the regulation of activated protein C
11. Deficiency of protein C in congenital thrombotic disease.
12. Protein C deficiency in a Dutch family with thrombotic disease
13. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred
14. Deficiencies of protein C, an inhibitor of blood coagulation
15. Application of enzyme immunoassay to coagulation testing
16. Fast functional protein C assay using PROTAC, a novel protein C activator
17. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
18. The box plot: a simple visual method to interprete data
19. The significance of protein C antigen in acute and chronic liver biliary disease
20. The effect of fulminant hepatic failure on protein C antigen and activity
21. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation
22. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation
23. Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy